The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
September 3rd 2025
While the AI software offered nearly equivalent negative predictive value (NPV) to radiologist interpretation of digital mammograms and digital breast tomosynthesis (DBT) images, researchers noted that AI had significantly higher recall rates and false-positive results in patients with intermediate risk.
Week in Review, October 2, 2007
October 2nd 2007Imaging threats-some averted, others coming or at hand-punctuated the week.Features: CT took it on the chin during the first half of 2000, creating what one exec called the “toughest period in the industry for a decade.” It’s not looking good for Slovakia-or the rest of Europe, for that matter-as the Old World braces for fallout from a European directive that threatens to bring MR imaging to a standstill. The U.S. imaging community dodged a bullet, as Congress reauthorized the State Children’s Health Insurance Program. A pending “Medicare Severity DRG” could give CT vendors a shot in the arm, as hospital administrators look for ways to ensure that staff diagnose patients within the first 24 hours of admittance.
Positron imaging joins x-ray mammography alternatives
October 1st 2007Small-field-of-view positron imaging, optimized for breast cancer detection, is jockeying for position among several adjuncts to x-ray mammography. A proponent of the technology, Dr. Kathy Schilling, believes it has an edge over MRI.
Doppler ultrasound predicts chemotherapy success for breast cancer
September 24th 2007Doppler ultrasound breast tumor exams conducted prior to chemotherapy can reliably predict the outcome of treatment, according to research conducted in India. Most breast cancer is treated with chemotherapy prior to surgery. The traditional way to assess the success of this chemotherapy is to study tissue samples collected at surgery. In this study, researchers developed a scoring method using Doppler ultrasound to predict chemotherapy success.
Ultrasound proves effective for axillary staging of less common breast cancer
September 17th 2007Both ultrasound alone and ultrasound-guided fine-needle aspiration biopsy of lymph nodes are reliable ways to stage invasive lobular carcinoma, a form of breast cancer occurring in only 10% to 15% of cases. Although preoperative assessment can be quite challenging with this cancer, research from the University of Texas M.D. Anderson Cancer Center in Houston found ultrasound to be as effective for staging invasive lobular carcinoma as it is for the more common invasive ductal carcinoma.
Pathology innovations challenge conventional DCIS assumptions
September 1st 2007Large-screen photographs of cotton bolls, snakeskin, cacti, and trees saddled with the overgrowth of new limbs often star in provocative lectures about early-stage breast cancer by Dr. Laszlo Tabar, a pioneer in mammography education.
Contrary to its reputation, DCIS emerges as complex, maybe lethal
September 1st 2007Ductal carcinoma in situ often takes on an innocent guise in the mainstream media. It may be referred to as "precancerous" or "mostly harmless." Some say this common malignancy is overdiagnosed and overtreated.
Stanford CT symposium ignites both excitement and concern
September 1st 2007The Stanford International Symposium on Multidetector-Row CT has gained such momentum in its nine-year history that the next meeting will be in a larger venue in Las Vegas. The growing importance of multislice CT is reflected in the wide range of topics presented this year.
Naviscan hones PET to manage breast cancer patients
August 28th 2007Naviscan PET Systems hopes to ride a building wave of interest in new breast imaging technologies with its high-resolution, small field-of-view positron system. The FDA-cleared device has obvious application as an adjunct in the diagnosis of breast cancer. But it may be able to do much more.
MR, nuclear medicine show advantages over mammography
August 14th 2007Competitors to x-ray mammography may be mounting a serious challenge to the long-standing technology. Research has determined that MR and nuclear medicine can detect ductal carcinoma in situ (DCIS), which can develop into an invasive form of breast cancer, much earlier than mammography can.
Radiologists prove hasty in dismissing breast CAD
August 1st 2007Radiologists may be adept at rejecting hundreds of false positives flagged by computer-aided detection software, but they also have a strong tendency to dismiss correctly identified cancers, mistakenly believing the findings are benign, according to new research.
DRA crushes demand for big-ticket scanners
August 1st 2007Big-ticket items are suffering this year as reimbursement cuts resulting from the Deficit Reduction Act have had a wider and longer lasting effect than initially expected. Particularly hard hit has been PET/CT. The hybrid juggernaut had defied the odds for several years, marching forward with ever higher sales despite utilization rates at individual sites that allowed plenty of unused capacity.
Sophistication of breast ultrasound continues to grow
July 25th 2007For nearly a decade, radiologists have used breast ultrasound as an adjunct to x-ray mammography to avoid unnecessary biopsies in equivocal cancer cases. Now ultrasound innovations that increase image resolution while decreasing operator dependence are reflected in a study published in the July issue of Radiology.